the 183rd Issue: GSK finance head not allowed to leave

  Hot Topics
Global competition, protectionism contribute to increase in lawsuits
LONDON - Beijing is preventing GlaxoSmithKline’s head of finance for China from leaving the country, as police accuse the British drugmaker of bribing officials and doctors, a spokesman for the drugmaker said on Wednesday...
More
 
China, according to many experts who monitor its economy, has made big progress in recent years to protect the rights of patent-holders and other innovators. Enacting strong intellectual-property laws doesn’t necessarily mean they’re strictly enforced, however... More
 
Chinese generic drug makers are now preparing for a possible big payday when the patent on Pfizer’s blockbuster drug Viagra expires in China next July... More
 
  News in Brief
 
 
  China IP Articles
 
· Judicial Determination and Assumption of Liabilities for Trademark Infringement in Domain Name Disputes Issue 55, By Qi Jimin, Presiding Judge, Civil Law Court Division No. 3, The People’s Court of Huangpu District, Shanghai,[Trademark]
 
 [Case Overview]
From July 1987 to November 2004, the plaintiff (and appellee) SWAROVSKI AKTIENGESELLSCHAFT (SWAROVSKI) successively acquired the registered trademarks of “SWAROVSKI,” “施华洛世奇”, “ ” and “ .” These SWAROVSKI trademarks, which are still valid, are approved to be used on goods in Class 14 of the International Classification of Goods...
More
 
· Navigating the Trade Mark Landscape in Africa Issue 55, By Jacky He, Candidate Attorney at Spoor & Fisher South Africa,[Trademark]
 
Africa is the second-largest continent in the world, both in area and population. If one includes the surrounding islands there are almost 60 territories with a population of more than one billion people. Over the last decade Africa’s overall economic growth rate has approached that of Asia... More
 
 
Forward   Subscription   July 25th, 2013
   Our Products
Homepage          Cancel Subscription            Contact China IP
 
This Publication is subject to the ownership of China IP. Neither the publication nor any portion hereof may be reprinted, sold or redistributed without written consent of China IP